,72,73 For example, reduction of intracellular levels of the PARP substrate NAD+ via inhibition of nicotinamide phosphoribosyltransferase (NAMPT) or high levels of the NAD+ derivative NADP+ reduce PARP activity and thereby enhance sensitivity of cancer cells to PARPis.71 This evidence concerns the gene PARP1 and cancer.